About the Authors
- Joseph Schober
-
Roles Conceptualization, Investigation, Supervision, Writing – review & editing
* E-mail: joschob@siue.edu
Affiliation Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, Illinois, United States of America
- Jahnavi Polina
-
Roles Investigation, Methodology
Affiliation Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, Illinois, United States of America
- Field Walters
-
Roles Investigation, Methodology
Affiliation Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, Illinois, United States of America
- Nathan Scott
-
Roles Investigation, Methodology
Affiliation Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, Illinois, United States of America
- Eric Lodholz
-
Roles Investigation, Methodology
Affiliation Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, Illinois, United States of America
- Albert Crider
-
Roles Resources
Affiliation Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, Illinois, United States of America
- Karin Sandoval
-
Roles Data curation, Formal analysis, Writing – original draft, Writing – review & editing
Affiliation Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, Illinois, United States of America
- Ken Witt
-
Roles Conceptualization, Funding acquisition, Investigation, Resources, Supervision, Writing – original draft, Writing – review & editing
Affiliation Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, Illinois, United States of America
Competing Interests
Authors K. Witt, A. Crider, and K. Sandoval are co-inventors on patent applications for the development of SSTR4 agonists, through Southern Illinois University Edwardsville (USA patent application No. PCT/US2018/032368; European National Application No. 18798793.8, Japanese Application No. 2019-562574). Ken Witt is CEO of Somatolynk Inc., a company focused on advancement of SST4 agonists. These patent applications and the commercial affiliation with Somatolynk Inc. does not alter our adherence to PLOS ONE policies on sharing data and materials.